Richard M. O'Connor
Richard M. O'Connor
Verified email at mssm.edu
Title
Cited by
Cited by
Year
Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression
RM O'connor, TG Dinan, JF Cryan
Molecular psychiatry 17 (4), 359-376, 2012
1262012
microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus
RM O'Connor, S Grenham, TG Dinan, JF Cryan
International Journal of Neuropsychopharmacology 16 (8), 1885-1892, 2013
952013
Metabotropic glutamate receptor 7: at the interface of cognition and emotion
RM O'Connor, BC Finger, PJ Flor, JF Cryan
European journal of pharmacology 639 (1-3), 123-131, 2010
862010
Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms
RD Gosselin, RM O'Connor, M Tramullas, M Julio–Pieper, TG Dinan, ...
Gastroenterology 138 (7), 2418-2425, 2010
852010
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes
MC Camp, KP MacPherson, L Lederle, C Graybeal, S Gaburro, ...
Neuropsychopharmacology 37 (6), 1534-1547, 2012
792012
Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice
OF O’Leary, RM O’Connor, JF Cryan
Neuropharmacology 62 (1), 247-255, 2012
622012
MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
A Gururajan, ME Naughton, KA Scott, RM O'connor, G Moloney, G Clarke, ...
Translational psychiatry 6 (8), e862-e862, 2016
432016
Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment
RM O'Connor, MM Pusceddu, TG Dinan, JF Cryan
Neuropharmacology 66, 236-241, 2013
372013
Adolescent brain vulnerability and psychopathology through the generations: role of diet and dopamine
RM O’Connor, JF Cryan
Biological psychiatry 75 (1), 4-6, 2014
332014
P-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodents
FE O'brien, RM O'connor, G Clarke, TG Dinan, BT Griffin, JF Cryan
Neuropsychopharmacology 38 (11), 2209-2219, 2013
332013
Metabotropic glutamate receptors in central nervous system diseases
A V Golubeva, R D Moloney, R M O'Connor, T G Dinan, J F Cryan
Current drug targets 17 (5), 538-616, 2016
312016
All roads lead to the miRNome: miRNAs have a central role in the molecular pathophysiology of psychiatric disorders
RM O’Connor, A Gururajan, TG Dinan, PJ Kenny, JF Cryan
Trends in pharmacological sciences 37 (12), 1029-1044, 2016
302016
Regulation of the brain–gut axis by group III metabotropic glutamate receptors
M Julio-Pieper, RM O’Connor, TG Dinan, JF Cryan
European journal of pharmacology 698 (1-3), 19-30, 2013
292013
Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse
RM O'Connor, DR Thakker, M Schmutz, H van der Putten, D Hoyer, ...
Neuropharmacology 72, 66-73, 2013
282013
The effects of mGlu7 receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains
RM O’Connor, JF Cryan
Behavioural Pharmacology 24 (2), 105-113, 2013
252013
Enhancing glutamatergic transmission during adolescence reverses early-life stress-induced deficits in the rewarding effects of cocaine in rats
RM O'Connor, RD Moloney, J Glennon, S Vlachou, JF Cryan
Neuropharmacology 99, 168-176, 2015
212015
Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man
OF O'Leary, FE O'Brien, RM O'Connor, JF Cryan
Pharmacology Biochemistry and Behavior 123, 55-76, 2014
192014
Habenular TCF7L2 links nicotine addiction to diabetes
A Duncan, MP Heyer, M Ishikawa, SPB Caligiuri, X Liu, Z Chen, ...
Nature 574 (7778), 372-377, 2019
172019
16 Role of metabotropic glutamate receptors in CNS disorders
RM O’Connor, JF Cryan
G protein-coupled receptors: structure, signaling, and physiology, 321, 2010
152010
The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram
FE O’Brien, RM O’Connor, G Clarke, MD Donovan, TG Dinan, BT Griffin, ...
Behavioural brain research 261, 17-25, 2014
112014
The system can't perform the operation now. Try again later.
Articles 1–20